Skip to main content
Quest for Growth NV logo

Quest for Growth NV — Investor Relations & Filings

Ticker · QFG ISIN · BE0003730448 LEI · 549300RFN1RGQGRC9B35 BR Financial and insurance activities
Filings indexed 1,081 across all filing types
Latest filing 2015-07-01 Share Issue/Capital Cha…
Country BE Belgium
Listing BR QFG

About Quest for Growth NV

https://capricorn.be/en/channels/quest-…

Quest for Growth NV is a public alternative investment fund (AIF) with fixed capital, managed by Capricorn Partners NV. The company maintains a diversified portfolio with a preference for long-term investments. It focuses on both quoted and unquoted European growth companies, primarily targeting smaller capitalization and small to medium-sized enterprises in innovative sectors such as digital, health, and clean technologies. By integrating two asset classes, the fund offers investors access to venture and growth capital alongside smaller listed companies. Investments in private companies are often made in synergy with venture and growth capital funds managed by Capricorn Partners.

Recent filings

Filing Released Lang Actions
Kiadis Pharma, a Quest for Growth portfolio company, floats successfully
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 1, 2015, announcing that a portfolio company of Quest for Growth, Kiadis Pharma, successfully completed its Initial Public Offering (IPO) and raised €32.7 million. The text details the IPO price, listing dates, and the resulting valuation change for Quest for Growth's investment. Crucially, it mentions that the appreciation is included in the Net Asset Value (NAV) calculation as at June 30, 2015, which will be published on July 2. Since the document is an announcement about a corporate event (IPO) that impacts the portfolio's value and explicitly references the upcoming publication of the NAV calculation, it is primarily a corporate update related to capital structure/financing activities. However, the core subject is the successful listing of an investment, which falls under Capital/Financing Update (CAP). It is not the NAV report itself (NAV) nor the full earnings release (ER). Given the focus on the successful fundraising/listing of a portfolio company, CAP is the most appropriate fit, although it is structured as a press release (RPA/RNS territory). Since the content is substantive about a financing event, CAP is preferred over the general announcement codes.
2015-07-01 English
Kiadis Pharma, l'une des entreprises dans le portefeuille de Quest for Growth,
Report Publication Announcement Classification · 99% confidence The document is titled 'Communiqué de presse' (Press Release) dated July 1, 2015, and announces a specific corporate event: the successful Initial Public Offering (IPO) of Kiadis Pharma, a portfolio company of Quest for Growth. It details the fundraising amount, lock-up periods, and the resulting valuation change for Quest for Growth's holdings. This type of announcement, focusing on a significant corporate transaction (IPO of a portfolio company) and providing immediate financial impact details, is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing a specific event and its immediate financial consequences, and not a comprehensive periodic report (like 10-K or IR), ER is the most fitting category for immediate financial news. However, given the context of an investment company reporting on a portfolio company's IPO, it also functions as a significant corporate update. Because it is a formal press release announcing a major event and its financial implications, and it explicitly states the full press release is available online, it aligns closely with the function of an Earnings Release (ER) which often includes key highlights of recent performance/events, or potentially a Regulatory Filing (RNS) if it were less financially focused. Given the focus on the valuation impact ('valeur d'inventaire au 30 juin 2015, laquelle sera publiée le jeudi 2 juillet 2015'), ER is slightly favored over RNS, but the structure is very much that of a general regulatory announcement. Since it is a press release announcing a major event, and not a comprehensive report, and it is not a dividend notice, management discussion, or director dealing, I will classify it as an Earnings Release (ER) as it reports on a significant financial event impacting the company's value, or RNS as a general regulatory announcement. Given the content is a press release about a portfolio company's IPO and its effect on the NAV calculation, which is often bundled with earnings/period updates, ER is a strong candidate. However, the document itself is a press release announcing the IPO and the subsequent NAV calculation date, making it a general regulatory announcement about a significant event. I will select RNS as the most appropriate general regulatory announcement category for this specific type of corporate news release that isn't a standard periodic report or specific transaction notice like DIV or POS.
2015-07-01 French
Kiadis Pharma, één van de portefeuillebedrijven van Quest for Growth,
Report Publication Announcement Classification · 99% confidence The document is a press release dated July 1, 2015, from 'QUEST FOR GROWTH' concerning a portfolio company, Kiadis Pharma, successfully completing an IPO. The text announces the event, details the financial impact on Quest for Growth's portfolio valuation, and states that the inventory value calculation for June 30, 2015, 'will be published on Thursday, July 2nd.' Furthermore, the header mentions 'Publicatieschema op 1 juli 2015 : persmededeling beschikbaar op www.questforgrowth.com'. This structure—a brief announcement about a corporate event (IPO of a holding) and explicitly stating when the related financial report (inventory value) will be published—strongly suggests this document is an announcement regarding the publication of a report, rather than the report itself (like an IR or ER). Given the context of a financial holding company announcing portfolio news and referencing an upcoming valuation publication, the most fitting category is Report Publication Announcement (RPA). It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER), as it focuses on a specific event and points to future publication of the full valuation.
2015-07-01 Dutch
NAV per share on 31/05/2015: € 12.22
Net Asset Value Classification · 99% confidence The document explicitly states the 'NAV per share on 31/05/2015: € 12.22' and provides a table comparing the current Net Asset Value (NAV) per share with previous periods (31/12/2014, 30/04/2015). This content directly corresponds to the definition of a Net Asset Value update, which is classified as 'NAV'. The document is short and appears to be a direct announcement of this figure, not a comprehensive report.
2015-06-04 English
VNI par action au 31/05/2015: 12,22 EUR
Net Asset Value Classification · 99% confidence The document is a press release dated June 4, 2015, explicitly stating the 'VNI par action au 31/05/2015' (Net Asset Value per share as of May 31, 2015) is 12.22 EUR. It provides a comparison to the previous period's NAV (Dec 31, 2014) and includes the corresponding stock price. This content directly corresponds to the definition of a Net Asset Value (NAV) update, which is classified as 'NAV'. Although it is a press release, the core content is the NAV calculation, making NAV the most specific classification over a general RPA or RNS.
2015-06-04 French
NAV per aandeel op 31/05/2015: 12,22 €
Report Publication Announcement Classification · 99% confidence The document is a short press release (2792 characters) dated June 4, 2015, explicitly stating the 'NAV per aandeel op 31/05/2015: 12,22 €'. It provides the Net Asset Value (NAV) for the investment company Quest for Growth as of the end of May 2015, comparing it to the previous period end (Dec 31, 2014). This content directly matches the definition for Net Asset Value updates (NAV). Although it is a press release, the core information being conveyed is the NAV calculation, making 'NAV' the most specific classification over a general 'RPA' or 'RNS'.
2015-06-04 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.